IP Library › Assignment 050905/0290
Patent Assignment
Reel/Frame 050905/0290

Assignment of Assignor's Interest

Recorded: 2019-11-01 Pages: 27
Assignor
ACLARIS THERAPEUTICS, INC.
Executed: 2019-10-10
Assignee
EPI HEALTH, LLC
134 COLUMBUS ST, CHARLESTON, SOUTH CAROLINA, 29403
Covered Properties (21)
Compositions and Methods for Treating Purpura
Patent: 8,114,898 →
Application: 12/272,253 →
Publication: US 2009/0130027
Pharmaceutical Cream Compositions and Methods of Use
Patent: 8,883,838 →
Application: 13/309,403 →
Publication: US 2012/0149748
Compositions and Methods for Treating Purpura
Patent: 8,673,953 →
Application: 13/345,472 →
Publication: US 2012/0177585
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Application: 13/396,165 →
Publication: US 2012/0208858
Gel Compositions of Oxymetazoline and Methods of Use
Application: 13/548,009 →
Publication: US 2013/0079379
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Application: 14/144,106 →
Publication: US 2014/0113947
Compositions and Methods for Treating Purpura
Patent: 9,265,761 →
Application: 14/181,706 →
Publication: US 2014/0161749
Compositions and Methods for Treating Purpura
Application: 14/505,100 →
Publication: US 2015/0018358
Pharmaceutical Cream Compositions and Methods of Use
Application: 14/521,094 →
Publication: US 2015/0045403
Stabilized Oxymetazoline Formulations and Their Uses
Patent: 9,801,857 →
Application: 14/737,360 →
Publication: US 2015/0359781
Stabilized Oxymetazoline Formulations and Their Uses
Patent: 9,974,773 →
Application: 15/429,873 →
Publication: US 2017/0151217
Stabilized Oxymetazoline Formulations and Their Uses
Application: 15/984,918 →
Publication: US 2018/0263962
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Application: 16/267,590 →
Publication: US 2019/0167566
Stabilized Oxymetazoline Formulations and Their Uses
Application: 16/380,538 →
Publication: US 2019/0365713
Compositions and methods of treating purpura
Application: 60/988,564 →
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Application: 61/419,693 →
Cream Compositions and Methods of Use
Application: 61/419,697 →
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Application: 61/443,210 →
Gel Compositions of Oxymetazoline and Methods of Use
Application: 61/507,926 →
Oxymetazoline Cream for the Treatment of Erythema Associated with Rosacea
Application: 62/010,838 →
Stabilized Oxymetazoline Formulations and Their Uses
Application: 62/069,624 →
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 24, 2015
From: VICEPT THERAPEUTICS, INC.
To: ALLERGAN, INC.
Reel/Frame 035244/0187 →
Assignment of Assignor's Interest Mar 24, 2015
From: VICEPT THERAPEUTICS, INC.
To: ALLERGAN, INC.
Reel/Frame 035244/0255 →
Assignment of Assignor's Interest Apr 22, 2015
From: SARPOTDAR, PRAMOD; WARNER, KEVIN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 035467/0897 →
Assignment of Assignor's Interest Apr 24, 2015
From: SHANLER, STUART D.
To: ALLERGAN, INC.
Reel/Frame 035486/0811 →
Assignment of Assignor's Interest Apr 24, 2015
From: POWALA, CHRISTOPHER
To: ALLERGAN, INC.
Reel/Frame 035487/0062 →
Assignment of Assignor's Interest May 8, 2015
From: ZHANG, STEVEN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 035601/0275 →
Assignment of Assignor's Interest Jul 2, 2015
From: SARPOTDAR, PRAMOD; WARNER, KEVIN; ZHANG, STEVEN; AHLUWALIA, GURPREET
To: ALLERGAN, INC.
Reel/Frame 035973/0574 →
Assignment of Assignor's Interest Feb 10, 2017
From: SARPOTDAR, PRAMOD; WARNER, KEVIN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 041227/0329 →
Assignment of Assignor's Interest May 21, 2018
From: SARPOTDAR, PARMOD; WARNER, KEVIN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 045862/0849 →
Assignment of Assignor's Interest Dec 5, 2018
From: ALLERGAN, INC.
To: ACLARIS THERAPEUTICS, INC.
Reel/Frame 047681/0466 →
Assignment of Assignor's Interest Aug 13, 2019
From: ALLERGAN, INC.
To: ACLARIS THERAPEUTICS, INC.
Reel/Frame 050038/0283 →
Assignment of Assignor's Interest Aug 13, 2019
From: SARPOTDAR, PRAMOD; WARNER, KEVIN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 050038/0231 →
Security Interest Mar 14, 2022
From: EPI HEALTH, LLC
To: EVENING POST GROUP, LLC
Reel/Frame 059364/0509 →
Release of Security Interest Jan 11, 2023
From: EVENING POST GROUP, LLC
To: EPI HEALTH, LLC
Reel/Frame 062347/0129 →
Assignment of Assignor's Interest Dec 11, 2024
From: ALLERGAN, INC.
To: ACLARIS THERAPEUTICS, INC.
Reel/Frame 069557/0318 →
Assignment of Assignor's Interest Dec 11, 2024
From: ACLARIS THERAPEUTICS, INC.
To: EPI HEALTH, LLC
Reel/Frame 069599/0614 →
Assignment of Assignor's Interest Dec 11, 2024
From: EPI HEALTH, LLC
To: MAYNE PHARMA LLC
Reel/Frame 069557/0372 →
Assignment of Assignor's Interest Dec 11, 2024
From: SARPOTDAR, PRAMOD; WARNER, KEVIN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 069557/0245 →